Page last updated: 2024-08-24

opc 14117 and Cognition Disorders

opc 14117 has been researched along with Cognition Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyama, N; Katayama, Y; Kawamata, T; Kikuchi, T; Maeda, T; Mori, T; Uwahodo, Y; Yamamoto, T1

Trials

1 trial(s) available for opc 14117 and Cognition Disorders

ArticleYear
Vitamin E drug.
    Treatment review, 1995, Issue:no 18

    Topics: AIDS Dementia Complex; Antioxidants; Cognition Disorders; Free Radical Scavengers; HIV Infections; Humans; Indans; Piperazines; Placebos; Randomized Controlled Trials as Topic; Vitamin E

1995

Other Studies

1 other study(ies) available for opc 14117 and Cognition Disorders

ArticleYear
Effects of antioxidant, OPC-14117, on secondary cellular damage and behavioral deficits following cortical contusion in the rat.
    Brain research, 2002, May-03, Volume: 934, Issue:2

    Topics: Animals; Antioxidants; Behavior, Animal; Body Temperature; Brain Edema; Brain Injuries; Cell Death; Cerebral Cortex; Cognition Disorders; Hippocampus; Indans; Male; Maze Learning; Necrosis; Nerve Degeneration; Osmolar Concentration; Oxidative Stress; Piperazines; Rats; Rats, Wistar; Specific Gravity; Time Factors

2002